Brief: Talis Biomedical Provides Business Update And Reports Second Quarter Financial Results
Aug 2 (Reuters) - Talis Biomedical Corp TLIS.O :
* TALIS BIOMEDICAL PROVIDES BUSINESS UPDATE AND REPORTS
SECOND
QUARTER FINANCIAL RESULTS
* Q2 REVENUE $600,000
* REVENUE WAS $0.6 MILLION FOR Q2 OF 2022, COMPARED TO $0.1
MILLION
* NET LOSS WAS $27.0 MILLION FOR Q2 OF 2022, COMPARED TO
$64.5
MILLION
Source text for Eikon: ID:nGNX8mCHhk
Further company coverage: TLIS.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Talis Biomedical
See all newsBrief: Talis Biomedical Says Nasdaq Believes Co Is 'Public Shell' And Continued Listing Of Its Common Stock Is No Longer Warranted
Brief: Talis Biomedical Says Accepting Voluntary Resignation Of Heinrich Dreismann From Board Effective August 1
Brief: Talis Biomedical Eliminates Andrew Lukowiak As President And Chief Scientific Officer
Talis Biomedical up on plans to explore strategic options, job cuts
Brief: Talis Biomedical Announces Exploration Of Strategic Alternatives And Cost Reduction Plan To Preserve Cash